#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14850	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2518	721.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1869	1869	T	949	T,C,A	714,232,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14850	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2518	721.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1603	1603	C	965	C,G	963,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25314	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4094	769.8	0	.	n	.	0	T695C	SNP	695	695	T	1300	1300	C	942	C,A,G,T	936,2,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25314	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4094	769.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1942	1942	A	1004	A,C,G	999,4,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25314	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4094	769.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2576	2576	C	909	C	907	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25314	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4094	769.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2650	2650	A	827	A,G,C	825,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25314	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4094	769.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3202	3202	C	880	C,A,T	877,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2198	folP	855	855	100.0	folP.l15.c4.ctg.1	2159	127.0	1	SNP	p	R229S	0	.	.	685	687	CGC	1343	1345	CGC	239;240;241	C;G,A;C	239;239,1;241	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5842	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3891	186.9	1	SNP	p	S91F	0	.	.	271	273	TCC	843	845	TCC	210;211;212	T;C;C	210;211;212	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5842	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3891	186.9	1	SNP	p	D95G	0	.	.	283	285	GAC	855	857	GAC	213;214;213	G,T;A;C	212,1;214;213	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5842	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3891	186.9	1	SNP	p	D95N	0	.	.	283	285	GAC	855	857	GAC	213;214;213	G,T;A;C	212,1;214;213	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	2026	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1804	139.6	0	.	p	.	0	S32W	NONSYN	94	96	TCG	750	752	TGG	229;230;226	T;G;G	229;230;226	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	2026	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1804	139.6	0	.	p	.	0	D79N	NONSYN	235	237	GAT	891	893	AAT	237;236;235	A,C;A;T	236,1;236;235	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	2026	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1804	139.6	1	SNP	p	G45D	0	.	.	133	135	GGC	789	791	GGC	210;211;213	G;G,A;C	210;210,1;213	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1164	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1575	92.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5396	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3523	190.9	1	SNP	p	D86N	0	.	.	256	258	GAC	899	901	GAC	246;245;246	G;A,C;C	246;243,2;246	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5396	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3523	190.9	1	SNP	p	S88P	0	.	.	262	264	TCC	905	907	TCC	250;251;251	T;C;C	250;251;251	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4418	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3245	169.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1858	1860	GGC	226;224;221	G;G;C,G	226;224;220,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4166	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2922	177.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1612	1614	GCA	233;233;235	G,T;C,T;A	232,1;232,1;235	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4166	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2922	177.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1615	1617	ATC	232;234;234	A;T;C,A	232;234;233,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4166	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2922	177.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1627	1629	GTG	242;243;244	G,T;T;G,T	241,1;243;243,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4166	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2922	177.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1627	1629	GTG	242;243;244	G,T;T;G,T	241,1;243;243,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4166	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2922	177.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2131	2133	ACC	211;214;213	A,G;C,G;C	209,2;213,1;213	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4166	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2922	177.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2185	2187	GCG	223;222;224	G,A;C;G	222,1;222;224	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4166	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2922	177.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2185	2187	GCG	223;222;224	G,A;C;G	222,1;222;224	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4166	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2922	177.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2308	2310	GGC	210;211;213	G;G,C;C	210;210,1;213	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4166	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2922	177.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2317	2319	GGC	215;214;217	G,T;G;C	214,1;214;217	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4166	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2922	177.2	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2335	2337	CTG	232;231;233	C,G,A;T,C;G,T	229,1,1;229,1;231,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5628	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3510	199.4	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1823	1825	CCG	226;223;221	C;C,T,G;G,A	226;221,1,1;220,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2640	porA	1146	1146	99.83	porA.l15.c30.ctg.1	2535	129.9	0	.	p	.	0	S22G	NONSYN	64	66	AGC	666	668	GGC	181;181;184	G;G;C	181;181;184	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2640	porA	1146	1146	99.83	porA.l15.c30.ctg.1	2535	129.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	848	848	C	185	C,G	183,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	T18M	NONSYN	52	54	ACG	625	627	ATG	242;240;238	A;T;G,A	242;240;237,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	R40T	NONSYN	118	120	CGG	691	693	ACA	240;237;237	A,G;C,G;A	239,1;236,1;237	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	E41D	NONSYN	121	123	GAA	694	696	GAC	235;234;234	G;A;C,G	235;234;233,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	V45S	NONSYN	133	135	GTT	706	708	AGT	242;243;244	A,G;G;T,C	241,1;243;243,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	G46K	NONSYN	136	138	GGC	709	711	AAA	245;245;244	A,C;A;A	244,1;245;244	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	S54A	NONSYN	160	162	TCC	733	735	GCC	242;243;245	G;C,A;C	242;242,1;245	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	V98I	NONSYN	292	294	GTC	865	867	ATC	235;237;239	A;T,G;C	235;235,2;239	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	G189N	NONSYN	565	567	GGC	1138	1140	AAC	284;285;284	A;A;C,G	284;285;283,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	I209M	NONSYN	625	627	ATC	1198	1200	ATG	271;269;272	A;T;G,C	270;269;271,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	E210_Y211insR	INS	628	628	G	1201	1201	G	273	G	273	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1207	1207	T	259	T	259	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	1	SNP	p	G120K	0	.	.	358	360	GGT	931	933	GGT	251;249;249	G,A;G,T,C;T	250,1;247,1,1;249	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	1	SNP	p	A121N	0	.	.	361	363	GCC	934	936	GCC	246;245;246	G,T;C,T,G;C	244,2;242,2,1;246	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2830	porB1b	1035	1035	95.61	porB1b.l15.c17.ctg.1	2140	164.2	1	SNP	p	A121D	0	.	.	361	363	GCC	934	936	GCC	246;245;246	G,T;C,T,G;C	244,2;242,2,1;246	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	234	porB3	990	162	93.83	porB3.l15.c4.ctg.2	164	48.0	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	63;63;63	A;C;T	63;63;63	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	234	porB3	990	162	93.83	porB3.l15.c4.ctg.2	164	48.0	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	63;63;63	A;G;T	63;63;63	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	234	porB3	990	162	93.83	porB3.l15.c4.ctg.2	164	48.0	0	.	p	.	0	K278D	NONSYN	832	834	AAA	77	79	GAC	63;63;63	G;A;C	63;63;63	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	234	porB3	990	162	93.83	porB3.l15.c4.ctg.2	164	48.0	0	.	p	.	0	R279Y	NONSYN	835	837	CGC	80	82	TAC	63;63;63	T;A;C	63;63;63	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10032	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5435	230.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1502	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1442	129.2	1	SNP	p	V57M	1	.	.	169	171	ATG	774	776	ATG	267;264;266	A;T;G	267;264;266	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	M177T	NONSYN	529	531	ATG	1238	1240	ACG	561;565;564	A;C,T,A,G;G	561;561,1,2,1;564	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	1259	1261	GAC	564;563;564	G,T;A,G,C;C	562,1;560,2,1;564	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	T190M	NONSYN	568	570	ACG	1277	1279	ATG	554;551;552	A;T;G	554;551;552	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1289	1291	TCA	529;526;530	T,G,C,A;C;A	526,1,1,1;526;530	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1334	1336	CAG	508;496;484	C,G,T,A;A;G,A	505,1,1,1;496;483,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1355	1357	CTT	475;471;472	C,A;T;T,A	473,1;470;471,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1376	1378	AGT	475;478;481	A,C;G;T	473,1;478;481	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1445	1447	CCG	484;484;486	C;C;G,A	484;484;484,2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1547	1549	TCG	611;615;611	T;C,G,T;G,A	611;611,2,2;609,2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1718	1720	AAA	260;261;257	A,C;A;A	259,1;261;257	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1721	1723	AAG	254;247;246	A;A,C;G	254;246,1;246	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1736	1738	CAC	255;255;252	C,G;A;C	254,1;255;252	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1775	1777	GAA	325;325;332	G,A;A,T;A	324,1;324,1;332	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1853	1855	ACG	450;448;443	A;C;G	450;448;443	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1904	1906	ATT	448;442;445	A;T;T	448;442;445	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1907	1909	AGT	444;447;449	A,C,T;G;TG,T	441,2,1;447;440,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1946	1948	CTA	439;442;442	C,T;T;A	438,1;442;442	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1988	1990	AAT	459;464;462	A;A,T;T,A	459;463,1;461,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	2057	2059	TCA	446;445;439	T,A;C,A;A,C	445,1;443,1;437,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	2081	2083	ATG	409;412;409	A,T;T;G	408,1;412;409	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2375	2377	ACC	513;514;512	A;C,G;C,T,G	513;513,1;510,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	10644	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	3303	402.2	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2471	2473	GAA	570;566;567	G;A,C;A,T,C	570;565,1;565,1,1	.	Tetracycline resistance
